Literature DB >> 7779700

The recruitment of patients into clinical trials.

I F Tannock.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7779700      PMCID： PMC2033812          DOI： 10.1038/bjc.1995.221

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  8 in total

1.  Redressing the balance--the ethics of not entering an eligible patient on a randomised clinical trial.

Authors:  E Segelov; M H Tattersall; A S Coates
Journal:  Ann Oncol       Date:  1992-02       Impact factor: 32.976

2.  Selection of patients for randomized controlled trials: implications of wide or narrow eligibility criteria.

Authors:  S Yusuf; P Held; K K Teo; E R Toretsky
Journal:  Stat Med       Date:  1990 Jan-Feb       Impact factor: 2.373

3.  Equipoise and the ethics of clinical research.

Authors:  B Freedman
Journal:  N Engl J Med       Date:  1987-07-16       Impact factor: 91.245

Review 4.  A decade of breast cancer clinical investigation: results as reported in the Program/Proceedings of the American Society of Clinical Oncology.

Authors:  R T Chlebowski; L M Lillington
Journal:  J Clin Oncol       Date:  1994-09       Impact factor: 44.544

5.  Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer.

Authors:  K M Taylor; R G Margolese; C L Soskolne
Journal:  N Engl J Med       Date:  1984-05-24       Impact factor: 91.245

Review 6.  AXIS--a suitable case for treatment. UK Coordinating Committee on Cancer Research (UKCCCR) Colorectal Cancer Subcommittee.

Authors:  R Gray; R James; J Mossman; S Stenning
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

7.  Are treatment strategies of urologic oncologists influenced by the opinions of their colleagues?

Authors:  M J Moore; B O'Sullivan; I F Tannock
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

8.  Clinical trials in cancer: the role of surrogate patients in defining what constitutes an ethically acceptable clinical experiment.

Authors:  W J Mackillop; M J Palmer; B O'Sullivan; G K Ward; R Steele; G Dotsikas
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640
  8 in total
  2 in total

1.  A survey of the views of palliative care healthcare professionals towards referring cancer patients to participate in randomized controlled trials in palliative care.

Authors:  Clare White; Kristen Gilshenan; Janet Hardy
Journal:  Support Care Cancer       Date:  2008-05-01       Impact factor: 3.603

2.  Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy.

Authors:  Z A Nurgat; W Craig; N C Campbell; J D Bissett; J Cassidy; M C Nicolson
Journal:  Br J Cancer       Date:  2005-03-28       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.